Kausik K. Ray

1995–2026 年に発表

別表記
Kausik K Ray
275
論文数
81,893
被引用数
117
h 指数
259
i10 指数

被引用数

Kausik K. Ray の年別被引用数1972 年: 被引用 1 件1984 年: 被引用 1 件1985 年: 被引用 5 件1990 年: 被引用 1 件1991 年: 被引用 2 件1993 年: 被引用 1 件1995 年: 被引用 2 件1996 年: 被引用 6 件1997 年: 被引用 15 件1998 年: 被引用 15 件1999 年: 被引用 18 件2000 年: 被引用 32 件2001 年: 被引用 29 件2002 年: 被引用 25 件2003 年: 被引用 35 件2004 年: 被引用 38 件2005 年: 被引用 46 件2006 年: 被引用 42 件2007 年: 被引用 75 件2008 年: 被引用 53 件2009 年: 被引用 65 件2010 年: 被引用 78 件2011 年: 被引用 150 件2012 年: 被引用 163 件2013 年: 被引用 202 件2014 年: 被引用 259 件2015 年: 被引用 335 件2016 年: 被引用 517 件2017 年: 被引用 424 件2018 年: 被引用 514 件2019 年: 被引用 2,044 件2020 年: 被引用 2,815 件2021 年: 被引用 3,384 件2022 年: 被引用 3,478 件2023 年: 被引用 3,266 件2024 年: 被引用 5,103 件2025 年: 被引用 2,649 件2026 年: 被引用 193 件1973〜1983 年は被引用が無いため表示していません1986〜1989 年は被引用が無いため表示していません1992 年は被引用が無いため表示していません1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,256 件、この内訳の 17%イギリス: 引用元論文 2,465 件、この内訳の 8%中国: 引用元論文 2,265 件、この内訳の 7.3%イタリア: 引用元論文 1,974 件、この内訳の 6.4%ドイツ: 引用元論文 1,396 件、この内訳の 4.5%カナダ: 引用元論文 1,303 件、この内訳の 4.2%オーストラリア: 引用元論文 1,140 件、この内訳の 3.7%オランダ: 引用元論文 1,136 件、この内訳の 3.7%スペイン: 引用元論文 911 件、この内訳の 2.9%フランス: 引用元論文 909 件、この内訳の 2.9%スウェーデン: 引用元論文 727 件、この内訳の 2.3%ポーランド: 引用元論文 699 件、この内訳の 2.3%
0%17%その他 34.8%

分野

  • Medicine76.7%
  • Biochemistry, Genetics and Molecular Biology13.3%
  • Immunology and Microbiology2.7%
  • Nursing2.2%
  • Neuroscience0.8%
  • Health Professions0.7%
  • その他3.6%

トピック

  • Lipoproteins and Cardiovascular Health11.2%
  • Diabetes, Cardiovascular Risks, and Lipoproteins6.7%
  • Diabetes Treatment and Management4%
  • Atherosclerosis and Cardiovascular Diseases2.5%
  • Cancer, Lipids, and Metabolism2.4%
  • Acute Myocardial Infarction Research2%
  • その他71.2%

共著者

全論文

検索で開く
  1. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Goran Krstačić, Ekaterini Lambrinou, Basil S. Lewis, Josep Masip, Philippe Moulin, Steffen E. Petersen, Anna Sonia Petronio, Massimo Piepoli, Xavier Pintó, Lorenz Räber, Kausik K. Ray, Željko Reiner, Walter F. Riesen, Marco Roffi, Jean-Paul Schmid, Е. V. Shlyakhto, Iain A Simpson, Erik S.G. Stroes, Isabella Sudano, Alexandros D. Tselepis, Margus Viigimaa, Cécile Vindis, Alexander Vonbank, Michal Vrablik, Mislav Vrsalović, José Luis Zamorano, Jean-Philippe Collet, Konstantinos C. Koskinas, Manuela Casula, Lina Badimon, M. John Chapman, Guy G De Backer, Victoria Delgado, Brian A. Ference, Ian M Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R Pedersen, Gabriele Riccardi, Dimitrios J Richter, Marc S. Sabatine, Marja‐Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund, Stephan Windecker, Victor Aboyans, Colin Baigent, Jean-Philippe Collet, Verónica Dean, Victoria Delgado, Donna Fitzsimons, Chris P Gale, Diederick E. Grobbee, Sigrun Halvorsen, Gerhard Hindricks, Bernard Iung, Peter Jüni, Hugo A. Katus, Ulf Landmesser, Christophe Leclercq, Maddalena Lettino, Basil S Lewis, Bela Merkely, Christian Mueller, Steffen E. Petersen, Anna Sonia Petronio, Dimitrios J Richter, Marco Roffi, Е. V. Shlyakhto ほか 54 名 - European Heart Journal 2019 被引用: 8,909

  2. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ESC Scientific Document Group, Guy De Backer, Vera Regitz‐Zagrosek, Anne Hege Aamodt, Magdy Abdelhamid, Victor Aboyans, Christian Albus, Riccardo Asteggiano, Magnus Bäck, Michael A. Borger, Carlos Brotons, Jelena Čelutkienė, Renata Cífková, Maja Čikeš, Francesco Cosentino, Nikolaos Dagres, Tine De Backer, Dirk De Bacquer, Victoria Delgado, Hester M. den Ruijter, Paul Dendale, Heinz Drexel, Volkmar Falk, Laurent Fauchier, Brian A. Ference, Jean Ferrières, Marc Ferrini, Miles Fisher, Danilo Fliser, Zlatko Fras, Dan Gaiță, Simona Giampaoli, Stephan Gielen, Ian Graham, Catriona Jennings, Torben Jørgensen, Alexandra Kautzky‐Willer, Maryam Kavousi, Wolfgang Köenig, А. О. Конради, Dipak Kotecha, Ulf Landmesser, Madalena Lettino, Basil S. Lewis, Aleš Linhart, Maja‐Lisa Løchen, Konstantinos Makrilakis, Giuseppe Mancia, Pedro Marques‐Vidal, John W. McEvoy, Paul McGreavy, Béla Merkely, Lis Neubeck, Jens Cosedis Nielsen, Joep Perk, Steffen E. Petersen, Anna Sonia Petronio, Massimo Piepoli, Nana Goar Pogosova, Eva Prescott, Kausik K. Ray, Željko Reiner, Dimitrios Richter, Lars Rydén, Е. V. Shlyakhto, Marta Sitges, Miguel Sousa‐Uva, Isabella Sudano, Monica Tiberi, Rhian M. Touyz ほか 33 名 - European Heart Journal 2021 被引用: 6,270

  3. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2017 被引用: 3,840

  4. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raffaele Bugiardini, Robert A. Byrne, Silvia Castelletti, Alaide Chieffo, Véronique Cornelissen, Filippo Crea, Victoria Delgado, Heinz Drexel, Marek Gierlotka, Sigrun Halvorsen, Kristina H. Haugaa, Ewa A. Jankowska, Hugo Katus, Tim Kinnaird, Jolanda Kluin, Vijay Kunadian, Ulf Landmesser, Christophe Leclercq, Maddalena Lettino, Leena Meinila, Darren Mylotte, Gjin Ndrepepa, Elmir Ömerovic, Roberto F.E. Pedretti, Steffen E. Petersen, Anna Sonia Petronio, Gianluca Pontone, Bogdan A Popescu, Tatjana Potpara, Kausik K. Ray, Flavio Luciano, Dimitrios Richter, Е. V. Shlyakhto, Iain A. Simpson, Miguel Sousa‐Uva, Robert F. Storey, Rhian M. Touyz, Marco Valgimigli, Pascal Vranckx, Robert W. Yeh, Emanuele Barbato, Olivier Barthélémy, Johann Bauersachs, Deepak L. Bhatt, Paul Dendale, Maria Dorobanţu, Thor Edvardsen, Thierry Folliguet, Chris P Gale, Martine Gilard, Alexander Jobs, Peter Jüni, Ekaterini Lambrinou, Basil S. Lewis, Julinda Mehilli, Emanuele Meliga, Béla Merkely, Christian Mueller, Marco Roffi, Frans H. Rutten, Dirk Sibbing, George C M Siontis - European Heart Journal 2020 被引用: 5,040

  5. Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol

    著者: , , , , , , , , , , - New England Journal of Medicine 2020 被引用: 1,564

  6. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

    著者: , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2022 被引用: 1,297

  7. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 被引用: 875

  8. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2020 被引用: 1,527

  9. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michał Tendera, Koutaro Yokote, Nina P. Paynter, Julie E. Buring, Peter Libby, Paul M. Ridker - New England Journal of Medicine 2022 被引用: 711

  10. Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

    著者: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 被引用: 1,174

  11. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk

    著者: , , , , , , , , , , , , , , , , , , , , , - JAMA 2020 被引用: 982

  12. Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia

    著者: , , , , , , , , , , - New England Journal of Medicine 2020 被引用: 801

  13. EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , the DA VINCI study - European Journal of Preventive Cardiology 2020 被引用: 767

  14. Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol

    著者: , , , , , , , , , , , , - New England Journal of Medicine 2017 被引用: 977

  15. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2013 被引用: 2,737

  16. Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial

    著者: , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2023 被引用: 308

  17. Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study

    著者: , , , , , , , , , , , , , , , , , - The Lancet Regional Health - Europe 2023 被引用: 308

  18. Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

    著者: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 被引用: 3,474

  19. Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol

    著者: , , , , , , , - New England Journal of Medicine 2019 被引用: 796

  20. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kyoichi Mizuno, Kausik K. Ray, Ian Ford - The Lancet 2010 被引用: 2,447

  21. Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease

    著者: , , , , , , , , , , , , , , , - JAMA 2019 被引用: 711

  22. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

    著者: , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2023 被引用: 331

  23. Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels

    著者: , , , , , , , , , , , , , , , - JAMA 2022 被引用: 283

  24. Lipoprotein(a) as a cardiovascular risk factor: current status

    著者: , , , , , , , , , , , , , , , , , , - European Heart Journal 2010 被引用: 1,795